Apixaban

ELIQUIS, ELIQUIS SPRINKLE

Factor Xa Inhibitor

NADAC/unit $5.5110

No Shortage Tier 1: 55.6% 2 Manufacturers 4 ANDAs

Apixaban prevents blood clots by inhibiting factor Xa, prescribed for atrial fibrillation and venous thromboembolism.

vs. brand ELIQUIS: Generic saves up to 45% per unit

Covered Lives

Generic Manufacturers

ACCORD HEALTHCARE INCBRISTOL MYERS SQUIBB COBRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTEREGCON HOLDINGS LLC

Explore in the Ecosystem

rxsaver.aiCompare prices for Apixaban drfinder.aiFind doctors who prescribe Apixaban rxpbm.aiPBM spread analysis for Apixaban clinicalrx.aiClinical profile: Apixaban

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.